Achumbre, Edna .

HRN: 01-25-86  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/10/2026
04/16/2026
IV
4.5gm LD Then 2.25gm Q8
Q8
CAP MR
Pending Pharmacy Acceptance 

 Indication:  EmpiricEmpirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: